194 related articles for article (PubMed ID: 3296903)
21. Ivermectin: a long-acting microfilaricidal agent.
Ette EI; Thomas WO; Achumba JI
DICP; 1990 Apr; 24(4):426-33. PubMed ID: 2183496
[TBL] [Abstract][Full Text] [Related]
22. Treatment of onchocerciasis. The ocular effects of ivermectin and diethylcarbamazine.
Taylor HR; Murphy RP; Newland HS; White AT; D'Anna SA; Keyvan-Larijani E; Aziz MA; Cupp EW; Greene BM
Arch Ophthalmol; 1986 Jun; 104(6):863-70. PubMed ID: 3521559
[TBL] [Abstract][Full Text] [Related]
23. Short report: impact of ivermectin community-level treatments on elimination of adult Onchocerca volvulus when individuals receive multiple treatments per year.
Cupp EW; Cupp MS
Am J Trop Med Hyg; 2005 Dec; 73(6):1159-61. PubMed ID: 16354830
[TBL] [Abstract][Full Text] [Related]
24. [The effect of ivermectin on the transmission of Onchocerca volvulus in southern Mexico].
Rodríguez-Pérez MA; Reyes-Villanueva F
Salud Publica Mex; 1994; 36(3):281-90. PubMed ID: 7940009
[TBL] [Abstract][Full Text] [Related]
25. [A study in the Ivory Coast (1985-1987) of the efficacy and tolerance of ivermectin (Mectizan) in human onchocerciasis. I. A comparative double-blind study of 220 patients with onchocerciasis treated with a single oral dose of 100, 150 or 200 mcg/kg].
Larivière M; Beauvais B; Aziz M; Garin JF; Abeloos J; Derouin F; Bamba M; Bossebceuf C; Ferly-Therizol M; Sarfati C
Bull Soc Pathol Exot Filiales; 1989 Jan; 82(1):35-47. PubMed ID: 2545366
[TBL] [Abstract][Full Text] [Related]
26. Controlled trial and dose-finding study of ivermectin for treatment of onchocerciasis.
White AT; Newland HS; Taylor HR; Erttmann KD; Keyvan-Larijani E; Nara A; Aziz MA; D'Anna SA; Williams PN; Greene BM
J Infect Dis; 1987 Sep; 156(3):463-70. PubMed ID: 3302053
[TBL] [Abstract][Full Text] [Related]
27. Ivermectin. A review of its antifilarial activity, pharmacokinetic properties and clinical efficacy in onchocerciasis.
Goa KL; McTavish D; Clissold SP
Drugs; 1991 Oct; 42(4):640-58. PubMed ID: 1723366
[TBL] [Abstract][Full Text] [Related]
28. The safety and efficacy of amocarzine in African onchocerciasis and the influence of ivermectin on the clinical and parasitological response to treatment.
Awadzi K; Opoku NO; Attah SK; Addy ET; Duke BO; Nyame PK; Kshirsagar NA
Ann Trop Med Parasitol; 1997 Apr; 91(3):281-96. PubMed ID: 9229021
[TBL] [Abstract][Full Text] [Related]
29. Seasonal biting pattern of Simulium damnosum s.l and its implications on onchocerciasis treatment with ivermectin.
Adewale B; Oyerinde JP; Mafe MA
West Afr J Med; 2008 Oct; 27(4):224-9. PubMed ID: 19469400
[TBL] [Abstract][Full Text] [Related]
30. A randomized, double-blind, controlled trial of the effects of ivermectin at normal and high doses, given annually or three-monthly, against Onchocerca volvulus: ophthalmological results.
Fobi G; Gardon J; Kamgno J; Aimard-Favennec L; Lafleur C; Gardon-Wendel N; Duke BO; Boussinesq M
Trans R Soc Trop Med Hyg; 2005 Apr; 99(4):279-89. PubMed ID: 15708387
[TBL] [Abstract][Full Text] [Related]
31. Verification of ineffectual activity of ivermectin against adult Onchocerca spp in the ligamentum nuchae of horses.
Lyons ET; Drudge JH; Tolliver SC
Am J Vet Res; 1988 Jul; 49(7):983-5. PubMed ID: 3421544
[TBL] [Abstract][Full Text] [Related]
32. Ivermectin effect on microfilariae of Onchocerca volvulus after a single oral dose in humans.
Soboslay PT; Newland HS; White AT; Erttmann KD; Albiez EJ; Taylor HR; Williams PN; Greene BM
Trop Med Parasitol; 1987 Mar; 38(1):8-10. PubMed ID: 3602843
[TBL] [Abstract][Full Text] [Related]
33. The embryogenesis of Onchocerca volvulus over the first year after a single dose of ivermectin.
Duke BO; Zea-Flores G; Muñoz B
Trop Med Parasitol; 1991 Sep; 42(3):175-80. PubMed ID: 1801140
[TBL] [Abstract][Full Text] [Related]
34. Onchocerciasis and human immunodeficiency virus in western Uganda: prevalences and treatment with ivermectin.
Fischer P; Kipp W; Kabwa P; Buttner DW
Am J Trop Med Hyg; 1995 Aug; 53(2):171-8. PubMed ID: 7677220
[TBL] [Abstract][Full Text] [Related]
35. Adverse systemic reactions to treatment of onchocerciasis with ivermectin at normal and high doses given annually or three-monthly.
Kamgno J; Gardon J; Gardon-Wendel N; Demanga-Ngangue ; Duke BO; Boussinesq M
Trans R Soc Trop Med Hyg; 2004 Aug; 98(8):496-504. PubMed ID: 15186939
[TBL] [Abstract][Full Text] [Related]
36. [Ivermectin and human onchocerciasis. A study of 234 onchocerciasis patients in the Republic of Mali].
Vingtain P; Pichard E; Ginoux J; Coulibaly SM; Bissan Y; Ranque P; Thillaye B
Bull Soc Pathol Exot Filiales; 1988; 81(2):260-70. PubMed ID: 3046772
[TBL] [Abstract][Full Text] [Related]
37. The effects of high-dose ivermectin regimens on Onchocerca volvulus in onchocerciasis patients.
Awadzi K; Attah SK; Addy ET; Opoku NO; Quartey BT
Trans R Soc Trop Med Hyg; 1999; 93(2):189-94. PubMed ID: 10450448
[TBL] [Abstract][Full Text] [Related]
38. Primary motives for demand of ivermectin drug in mass distribution programmes to control onchocerciasis.
Abanobi OC; Chukwuocha UM; Onwuiiliri CO; Opara KC
East Afr J Public Health; 2011 Mar; 8(1):33-7. PubMed ID: 22066280
[TBL] [Abstract][Full Text] [Related]
39. [Ivermectin in the treatment of onchocerciasis: feasibility, compliance and efficacy of a mass treatment].
Awissi D; Heuschkel C; Banla M; Schulz-Key H
Bull Soc Pathol Exot; 1991; 84(5 Pt 5):739-49. PubMed ID: 1819423
[TBL] [Abstract][Full Text] [Related]
40. Ivermectin imposes selection pressure on P-glycoprotein from Onchocerca volvulus: linkage disequilibrium and genotype diversity.
Ardelli BF; Guerriero SB; Prichard RK
Parasitology; 2006 Mar; 132(Pt 3):375-86. PubMed ID: 16280093
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
